Cargando…

Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll‐like receptors 7 and 8

This study evaluated the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single and multiple oral doses of enpatoran (formerly named M5049), a new toll‐like receptor (TLR) 7 and 8 dual antagonist, and the effect of food on a single dose in healthy participants. In this sing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Port, Andreas, Shaw, Jamie V., Klopp‐Schulze, Lena, Bytyqi, Afrim, Vetter, Claudia, Hussey, Elizabeth, Mammasse, Nadra, Ona, Victor, Bachmann, Angelika, Strugala, Denis, Reh, Christian, Goteti, Kosalaram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377444/ https://www.ncbi.nlm.nih.gov/pubmed/34414672 http://dx.doi.org/10.1002/prp2.842

Ejemplares similares

518. Model-informed Dose Selection of Dual Toll-like Receptor 7/8 Inhibitor Enpatoran (M5049) for the Treatment of COVID-19 Pneumonia
por: Klopp-Schulze, Lena, et al.
Publicado: (2021)

Applying Modeling and Simulations for Rational Dose Selection of Novel Toll‐Like Receptor 7/8 Inhibitor Enpatoran for Indications of High Medical Need
por: Klopp‐Schulze, Lena, et al.
Publicado: (2022)

Evobrutinib, a covalent Bruton’s tyrosine kinase inhibitor: Mass balance, elimination route, and metabolism in healthy participants
por: Scheible, Holger, et al.
Publicado: (2021)

Comparison of Various Phase I Combination Therapy Designs in Oncology for Evaluation of Early Tumor Shrinkage Using Simulations
por: Seurat, Jérémy, et al.
Publicado: (2020)

Assessment of the potential of the MET inhibitor tepotinib to affect the pharmacokinetics of CYP3A4 and P-gp substrates
por: Yalkinoglu, Özkan, et al.
Publicado: (2023)

Effect of PF-04634817, an Oral CCR2/5 Chemokine Receptor Antagonist, on Albuminuria in Adults with Overt Diabetic Nephropathy
por: Gale, Jeremy D., et al.
Publicado: (2018)

Case report of ectopic hepatic tissue, a rare finding during a laparoscopic cholecystectomy
por: Avdaj, Afrim, et al.
Publicado: (2020)

Case report of cholelithiasis in a patient with type 1 Gaucher disease
por: Avdaj, Afrim, et al.
Publicado: (2016)

Designing phase I oncology dose escalation using dose–exposure–toxicity models as a complementary approach to model‐based dose–toxicity models
por: Pantoja, Kristyn, et al.
Publicado: (2022)

To blind or not to blind first in human and exploratory clinical trials: Acceleration of development vs. risk of bias
por: Haertter, Sebastian, et al.
Publicado: (2021)

Exposure–response analyses for the MET inhibitor tepotinib including patients in the pivotal VISION trial: support for dosage recommendations
por: Xiong, Wenyuan, et al.
Publicado: (2022)

Review of Transporter Substrate, Inhibitor, and Inducer Characteristics of Cladribine
por: Hermann, Robert, et al.
Publicado: (2021)

Cladribine as a Potential Object of Nucleoside Transporter-Based Drug Interactions
por: Hermann, Robert, et al.
Publicado: (2021)

Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Patients Receiving 4–6 Cycles of Platinum-Based and Taxane-Based Chemotherapy: A Prospective, Single-Center Study from Kosovo
por: Myftiu, Blerim, et al.
Publicado: (2022)

Disease trajectory of SLE clinical endpoints and covariates affecting disease severity and probability of response: Analysis of pooled patient‐level placebo (Standard‐of‐Care) data to enable model‐informed drug development
por: Goteti, Kosalaram, et al.
Publicado: (2022)

Correction of Severe Knees Valgus Deformities in a Patient With Renal Osteodystrophy
por: Bytyqi, Cen, et al.
Publicado: (2022)

Management of Coxa Vara Septica and Pseudoarthrosis of the Femoral Neck: A Case Report
por: Bytyqi, Hasime Qorraj, et al.
Publicado: (2017)

Clubfeet and congenital constriction band syndrome
por: Shabani, Bujar, et al.
Publicado: (2021)

Odontogenic Tumors: A Review of 675 Cases in Eastern Libya
por: Goteti, Saravana HL
Publicado: (2016)

Clinical Pharmacokinetics and Pharmacodynamics of the Endothelin Receptor Antagonist Macitentan
por: Sidharta, P. N., et al.
Publicado: (2015)

Pharmacodynamics of the Glutamate Receptor Antagonists in the Rat Barrel Cortex
por: Vinokurova, Daria, et al.
Publicado: (2018)

Surface Toll-like receptor 3 expression in metastatic intestinal epithelial cells induces inflammatory cytokine production and promotes invasiveness
por: Bugge, Marit, et al.
Publicado: (2017)

First-in-Human Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MHV370, a Dual Inhibitor of Toll-Like Receptors 7 and 8, in Healthy Adults
por: Shisha, Tamas, et al.
Publicado: (2023)

Pharmacodynamics in hypothermia
por: Tveita, Torkjel
Publicado: (2012)

Pharmacodynamic Parameters of Pharmacokinetic/Pharmacodynamic (PK/PD) Integration Models
por: Zhang, Longfei, et al.
Publicado: (2022)

Single and Repeated Doses of EGb 761(®) do not Affect Pharmacokinetics or Pharmacodynamics of Rivaroxaban in Healthy Subjects
por: Hoerr, Robert, et al.
Publicado: (2022)

Persons with Chronic Spinal Cord Injury Have Decreased Natural Killer Cell and Increased Toll-Like Receptor/Inflammatory Gene Expression
por: Herman, Paige, et al.
Publicado: (2018)

Improved Neurological Outcome in a Patient With Complicated Mitral Valve Endocarditis Treated With Daptomycin-Rifampin Regimen
por: Fatmi, Syed S, et al.
Publicado: (2022)

Pharmacodynamics of Memantine: An Update
por: Rammes, G, et al.
Publicado: (2008)

Systems Pharmacology and Pharmacodynamics
por: van der Graaf, Piet H.
Publicado: (2017)

Pharmacokinetics and Pharmacodynamics of Posaconazole
por: Chen, Lu, et al.
Publicado: (2020)

Pharmacokinetics and Pharmacodynamics of Ibrexafungerp
por: McCarthy, Matthew William
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of Tedizolid
por: Iqbal, Khalid, et al.
Publicado: (2022)

Assessment of Antifungal Pharmacodynamics
por: Howard, Alex, et al.
Publicado: (2023)

The Pelvic Support Osteotomy After Type IVA Septic Arthritis of the Hip
por: Bytyqi, Cen, et al.
Publicado: (2014)

Toward a humanistic approach in psychiatry
por: Dangellia, Afrim
Publicado: (2007)

Phage-Antibiotic Combination Treatments: Antagonistic Impacts of Antibiotics on the Pharmacodynamics of Phage Therapy?
por: Abedon, Stephen T.
Publicado: (2019)

Biological Activity of Extracts of Red and Yellow Fruits of Cornus mas L.—An In Vitro Evaluation of Antioxidant Activity, Inhibitory Activity against α-Glucosidase, Acetylcholinesterase, and Binding Capacity to Human Serum Albumin
por: Dzydzan, Olha, et al.
Publicado: (2022)

Natural Products with Toll-Like Receptor 4 Antagonist Activity
por: Molteni, Monica, et al.
Publicado: (2018)

Meta-Analysis of Comparative Trials Evaluating a Prophylactic Single-Use Negative Pressure Wound Therapy System for the Prevention of Surgical Site Complications
por: Strugala, Vicki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g2a0l7jc8iu8fn45tpokl1lhnt